Company / Return on Assets (ROA)
TEVA PHARMACEUTICAL INDUSTRIES LTD Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
3.5%
FY2025
5-year range
-5.3% / 3.5%
FY2021-FY2025
Trend
+183.0%
vs FY2024
Sector context
#48 of 213
Health Care
What the data says
TEVA PHARMACEUTICAL INDUSTRIES LTD's return on assets (roa) of 3.5% is higher than 77% of companies in the Health Care sector (FY2025). Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -23.0% in FY2017 to 3.5% in FY2025.
Based on SEC 10-K filings.
3.5% in FY2025 with a 5-year CAGR of +11.3%. Top quartile in the Health Care sector.
Improved from -1.3% to 3.5% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +8.8pp
- 5-Year Change
- +11.3pp
- 10-Year Change
- -
Sector benchmark
+114.3% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 183.0% year-over-year.
- Currently 27.6pp above the Health Care sector average.
- Lowest return on assets (roa) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 3.5% | +183.0% |
| FY2024 | -4.2% | -223.3% |
| FY2023 | -1.3% | +75.8% |
| FY2022 | -5.3% | -712.6% |
| FY2021 | 0.9% | +111.0% |
| FY2020 | -7.9% | -352.9% |
| FY2019 | -1.7% | +50.8% |
| FY2018 | -3.5% | +84.6% |
| FY2017 | -23.0% | -6680.0% |
| FY2016 | 0.4% | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026